Last updated on August 2019

Patients with Heart Failure and currently on a loop diuretic


Brief description of study

The purpose of this study is to evaluate the action of the study drug on your kidneys and your ability to eliminate salt and water alongside a diuretic (furosemide).

The information gathered during this clinical trial may support further drug development, including larger trials in patients with heart failure.  The study drug is being developed with the intention of treating patients with heart failure.

Heart failure is a long-term illness where the heart has been damaged and does not pump blood through the body as well as it should. Symptoms of heart failure can include shortness of breath (dyspnoea), lack of energy (fatigue), build-up of fluid (oedema), chronic coughing/wheezing and confusion.

 

In recognition of the time and effort involved in taking part in this study, you will receive £994 (£644 study payment, £300 bonus and £50 for travel expenses) on completion of the study provided you comply fully with all the study requirements.

 

For more information about this study:

  • You may also contact us directly; Azar Alexander-Sefre can be reached via e-mail at a.sefre@richmondpharmacology.com or via phone at +44 (0) 207 042 5800

 

Clinical Study Identifier: TX227268

Find a site near you

Start Over

Richmond Pharmacology

1a Newcomen Street, London Bridge, London, London United Kingdom
  Connect »